The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis

Pharmaceuticals

Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community

Submitted by Roots_Analysis on 2020-11-10 06:50.

The “Neoantigen Targeted Therapies Market, 2019-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.

Market-Research

To order this detailed 320+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2020-11-09 07:21.

Presently, over 150 neoantigen targeted therapies are being evaluated for advanced cancer indications and are designed for delivery via different routes of administration

Pharmaceuticals

The use of neoantigens in therapy has demonstrated the ability to elicit a strong T cell mediated immune response. Several therapy candidates are being investigated both as monotherapies and in combination with various immune checkpoint inhibitors, such as atezolizumab, durvalumab, ipilimumab, ... Read more

Submitted by Roots_Analysis on 2020-11-09 07:20.

The neoantigen targeted therapies market is projected to grow at an annualized rate of 57%, till 2030

Market-Research

Roots Analysis has done a detailed study on Neoantigen Targeted Therapies, 2019-2030 ... Read more

Submitted by Roots_Analysis on 2020-11-09 07:19.

The neoantigen targeted therapies market is estimated to be worth USD 3 Billion in 2030, predicts Roots Analysis

Market-Research

Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveillance; these neoantigens have been shown to possess substantial therapeutic potential

Submitted by Roots_Analysis on 2020-11-09 07:19.

Neoantigen targeted therapies market projected to reach USD 3 Billion by 2030, growing at an annualized rate of 57%, claims Roots Analysis

Market-Research

Submitted by Roots_Analysis on 2020-11-09 07:18.

Microbial Contract Biomanufacturing Market, 2020-2030’’ report features an extensive study of the current market landscape and future opportunities associated with the microbial contract biomanufacturing market. The study also features a detailed analysis

Pharmaceuticals

To order this detailed 320+ page report, please visit this link

Key Inclusions

A detailed review of

Submitted by Roots_Analysis on 2020-11-09 07:12.

Over 115 companies, across the world, claim to offer a variety of product development, manufacturing and support services, for various types of biologics that are manufactured / expressed in microbial systems, claims Roots Analysis

Market-Research

Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems, which are both robust and cost friendly. Presently, a number of service provider

Submitted by Roots_Analysis on 2020-11-09 07:12.

The microbial contract biomanufacturing market is projected grow at an annualized rate of 8.7%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Microbial Contract Biomanufacturing Market, 2020-2030, covering key aspects of the industry and

Submitted by Roots_Analysis on 2020-11-09 07:10.

The microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030, predicts Roots Analysis

Market-Research

Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation biologics, offering lucrative opportunities for CMOs / CDMOs

Submitted by Roots_Analysis on 2020-11-09 07:09.

The microbial contract biomanufacturing market is projected to be worth USD 9.3 billion by 2030, growing at a CAGR of 8.7%, claims Roots Analysis

Market-Research

The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment

Submitted by Roots_Analysis on 2020-11-09 07:09.

The “Neoantigen Targeted Therapies Market, 2019-2030

Market-Research

Key Inclusions

A detailed assessment of the current market landscape, providing information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, type of molecule (small molecule and biologic), type

Submitted by Roots_Analysis on 2020-11-09 06:56.

Presently, over 150 neoantigen targeted therapies are being evaluated for advanced cancer

Market-Research

Submitted by Roots_Analysis on 2020-11-09 06:54.

The neoantigen targeted therapies market is projected to grow at an annualized rate of 57%

Market-Research

Roots Analysis has done a detailed study on Neoantigen Targeted Therapies, 2019-2030, covering ... Read more

Submitted by Roots_Analysis on 2020-11-09 06:52.

The neoantigen targeted therapies market is estimated to be worth USD 3 Billion in 2030

Market-Research

Submitted by Roots_Analysis on 2020-11-09 06:49.

Neoantigen targeted therapies market projected to reach USD 3 Billion by 2030

Market-Research

Submitted by Roots_Analysis on 2020-11-09 06:46.

The ‘‘Microbial Contract Biomanufacturing Market, 2020-2030

Market-Research

Key Inclusions

A detailed review of the current landscape of companies offering contract manufacturing services for biologics, using microbial expression systems, along with information on their year of establishment, company size, location of headquarters, number

Submitted by Roots_Analysis on 2020-11-09 06:28.

Over 115 companies, across the world, claim to offer a variety of product development

Market-Research

Submitted by Roots_Analysis on 2020-11-09 06:27.

The microbial contract biomanufacturing market is projected grow at an annualized rate of 8.7%

Market-Research

Roots Analysis has done a detailed study on Microbial Contract Biomanufacturing Market, 2020-2030, covering key aspects of the industry and

Submitted by Roots_Analysis on 2020-11-09 06:25.

The microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030

Market-Research

Submitted by Roots_Analysis on 2020-11-09 06:22.

Pages